Saba Capital Management’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.4M Sell
947,346
-1,169,828
-55% -$19.6M 0.49% 56
2025
Q4
$35.5M Sell
2,117,174
-469,478
-18% -$7.89M 1.19% 18
2025
Q3
$40.1M Sell
2,586,652
-430,887
-14% -$5.9M 1.33% 19
2025
Q2
$38.7M Sell
3,017,539
-170,866
-5% -$2.11M 1.05% 24
2025
Q1
$40.5M Sell
3,188,405
-241,618
-7% -$3.27M 1.11% 19
2024
Q4
$45M Buy
3,430,023
+32
+0% +$462 1.13% 21
2024
Q3
$51.7M Hold
3,429,991
1.14% 25
2024
Q2
$48.6M Buy
3,429,991
+967,844
+39% +$13.1M 1.07% 25
2024
Q1
$33.6M Buy
2,462,147
+1,040,847
+73% +$14.4M 0.74% 30
2023
Q4
$19.1M Buy
1,421,300
+1,149,693
+423% +$14.1M 0.47% 71
2023
Q3
$3.39M Buy
271,607
+134,644
+98% +$1.77M 0.11% 174
2023
Q2
$1.85M Buy
+136,963
New +$1.89M 0.06% 232

Other funds holding HQL